Notes
The study was funded by Janssen-Cilag SpA.
Reference
Marcellusi A, et al. Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective? Clinical Drug Investigation : 27 May 2016. Available from: URL: http://dx.doi.org/10.1007/s40261-016-0414-y
Rights and permissions
About this article
Cite this article
Early intervention worthwhile for hepatitis C. PharmacoEcon Outcomes News 755, 22 (2016). https://doi.org/10.1007/s40274-016-3129-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3129-7